Research and Development

A new Cancer Research UK study aims to unlock lung cancer’s secrets by tracking how lung tumours develop and evolve …

Medical devices firm Tissue Regenix has appointed Steven Couldwell as a non-executive director. With over 14 years of senior management …

Lundbeck and partner Otsuka have posted positive Phase II results for their experimental Alzheimer’s drug. The latest data show statistically …

Healthcare products firm WinchPharma has appointed Lyndon Nicholson as its new chief executive with immediate effect.  Nicholson will replace former …

A new study has found that the rate of dementia in Britain has decreased over the past two decades, contrary …

French pharma group Ipsen has snapped up privately-owned UK life sciences firm Syntaxin for an upfront payment of €28 million …

Speculation that Roche is considering a bid for rare disease specialist Alexion Pharmaceuticals has unleashed a flurry of comment – …

Popular culture in both films and literature depict pharma and scientists as part of a nefarious industry, hell bent on …

Contract development and manufacturing organisation Aesica has appointed Sven Thomas and David Ross as business development managers. Under the new …

Eli Lilly & Co is to run yet another trial of its Alzheimer’s drug solanezumab, which failed twice in Phase …

AstraZeneca’s chief financial officer and executive director Simon Lowth will leave the firm at the end of October. Lowth has …

A new survey undertaken by UCB has found that enthusiasm for science in the UK is high, but adds that …

A leading Japanese pharma group says that the sector should see investment in fighting diseases of the developing world as …

Health officials in China say they have found evidence GSK tried to generate sales and raise drug prices by bribing …

AstraZeneca has cemented its position in Cambridge, the UK location of its purpose-built global HQ from 2016, by signing deals …